These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38199080)

  • 1. Singlet oxygen-based photoelectrochemical detection of single-point mutations in the KRAS oncogene.
    Daems E; Bassini S; Mariën L; Op de Beeck H; Stratulat A; Zwaenepoel K; Vandamme T; Op de Beeck K; Koljenović S; Peeters M; Van Camp G; De Wael K
    Biosens Bioelectron; 2024 Apr; 249():115957. PubMed ID: 38199080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations.
    Amicarelli G; Shehi E; Makrigiorgos GM; Adlerstein D
    Nucleic Acids Res; 2007; 35(19):e131. PubMed ID: 17932053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piezoelectric Plate Sensor (PEPS) for Analysis of Specific KRAS Point Mutations at Low Copy Number in Urine Without DNA Isolation or Amplification.
    Kirimli CE; Shih WH; Shih WY
    Methods Mol Biol; 2017; 1572():327-348. PubMed ID: 28299698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Singlet oxygen-based photoelectrochemical detection of DNA.
    Shanmugam ST; Trashin S; De Wael K
    Biosens Bioelectron; 2022 Jan; 195():113652. PubMed ID: 34583105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.
    Kobunai T; Watanabe T; Yamamoto Y; Eshima K
    Biochem Biophys Res Commun; 2010 Apr; 395(1):158-62. PubMed ID: 20361930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of point mutations in KRAS oncogene by real-time PCR-based genotyping assay in GIT diseases.
    Ugorcakova J; Hlavaty T; Novotna T; Bukovska G
    Bratisl Lek Listy; 2012; 113(2):73-9. PubMed ID: 22394035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.
    Araki T; Shimizu K; Nakamura K; Nakamura T; Mitani Y; Obayashi K; Fujita Y; Kakegawa S; Miyamae Y; Kaira K; Ishidao T; Lezhava A; Hayashizaki Y; Takeyoshi I; Yamamoto K
    J Mol Diagn; 2010 Jan; 12(1):118-24. PubMed ID: 20007840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
    Ausch C; Buxhofer-Ausch V; Oberkanins C; Holzer B; Minai-Pour M; Jahn S; Dandachi N; Zeillinger R; Kriegshäuser G
    J Mol Diagn; 2009 Nov; 11(6):508-13. PubMed ID: 19797612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid screening assay for KRAS mutations by the modified smart amplification process.
    Tatsumi K; Mitani Y; Watanabe J; Takakura H; Hoshi K; Kawai Y; Kikuchi T; Kogo Y; Oguchi-Katayama A; Tomaru Y; Kanamori H; Baba M; Ishidao T; Usui K; Itoh M; Cizdziel PE; Lezhava A; Ueda M; Ichikawa Y; Endo I; Togo S; Shimada H; Hayashizaki Y
    J Mol Diagn; 2008 Nov; 10(6):520-6. PubMed ID: 18832461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toehold-mediated strand displacement reaction triggered isothermal DNA amplification for highly sensitive and selective fluorescent detection of single-base mutation.
    Zhu J; Ding Y; Liu X; Wang L; Jiang W
    Biosens Bioelectron; 2014 Sep; 59():276-81. PubMed ID: 24742973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.
    Damin F; Galbiati S; Soriani N; Burgio V; Ronzoni M; Ferrari M; Chiari M
    PLoS One; 2018; 13(12):e0207876. PubMed ID: 30562355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
    Perez K; Walsh R; Brilliant K; Noble L; Yakirevich E; Breese V; Jackson C; Chatterjee D; Pricolo V; Roth L; Shah N; Cataldo T; Safran H; Hixson D; Quesenberry P
    Exp Mol Pathol; 2013 Aug; 95(1):74-82. PubMed ID: 23528430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes.
    Oh JE; Lim HS; An CH; Jeong EG; Han JY; Lee SH; Yoo NJ
    J Mol Diagn; 2010 Jul; 12(4):418-24. PubMed ID: 20413678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer.
    Kristensen LS; Kjeldsen TE; Hager H; Hansen LL
    BMC Cancer; 2012 Nov; 12():548. PubMed ID: 23173730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
    Borràs E; Jurado I; Hernan I; Gamundi MJ; Dias M; Martí I; Mañé B; Arcusa A; Agúndez JA; Blanca M; Carballo M
    BMC Cancer; 2011 Sep; 11():406. PubMed ID: 21943394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.
    Dono M; Massucco C; Chiara S; Sonaglio C; Mora M; Truini A; Cerruti G; Zoppoli G; Ballestrero A; Truini M; Ferrarini M; Zupo S
    Mol Med; 2013 Feb; 18(1):1519-26. PubMed ID: 23255073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing.
    Milbury CA; Correll M; Quackenbush J; Rubio R; Makrigiorgos GM
    Clin Chem; 2012 Mar; 58(3):580-9. PubMed ID: 22194627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel.
    Schleifman EB; Tam R; Patel R; Tsan A; Sumiyoshi T; Fu L; Desai R; Schoenbrunner N; Myers TW; Bauer K; Smith E; Raja R
    PLoS One; 2014; 9(3):e90761. PubMed ID: 24658394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.